{
  "drug_name": "Diclofenac",
  "url": "https://wikem.org/wiki/Diclofenac",
  "scraped_at": "2026-01-10T03:14:00.561137",
  "sections": {
    "General": {
      "text": "Type:\nNSAID\nDosage Forms: Capsule 18mg, 25mg, 35mg; ER Tablet 100mg, 0.1% opthalmic solution, topical gel 1-3%\nCommon Trade Names: Zorvolex",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "NSAID",
          "url": "https://wikem.org/wiki/NSAID"
        }
      ]
    },
    "Adult_Dosing": {
      "text": "",
      "subsections": {
        "Pain,_mild-moderate": {
          "text": "Tablet PO 50mg TID, may administer 100mg as first dose",
          "tables": []
        },
        "Ankylosing_Spondylitis": {
          "text": "PO Delayed Release 25mg 4x daily and 25mg qhs prn",
          "tables": []
        },
        "Osteoarthritis": {
          "text": "35mg PO TID",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Pediatric_Dosing": {
      "text": "NA",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "Pregnancy Rating\n: C, category D if >30wks after gestation\nLactation: probably safe\nRenal dosing: monitor renal function closely if advanced renal disease\nHepatic dosing: max 54mg/day",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Pregnancy Rating",
          "url": "https://wikem.org/wiki/Pregnancy_Rating"
        }
      ]
    },
    "Contraindications": {
      "text": "allergy to class/drug\nASA or NSAID-induced asthma or urticaria\ncaution if:\nrenal impairment, dehydration, elderly or debilitated\nhistory of GI bleed or ulcers, alcohol use, or coagulopathy\nhepatic impairment\nasthma\ncardiovascular disease (or high risk of), including CABG surgery periop use, recent MI, CHF, HTN, smoker\nfluid retention\nPKU\nprolonged use",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "Serious\nGI bleed, ulcer, perforation\nblood dyscrasias, prolonged bleeding time, anemia\nnephrotoxicity, renal papillary necrosis\nMI, stroke, thromboembolism, HTN, CHF\nhepatotoxicity, hepatic necrosis, pancreatitis\nbronchospasm\nexfoliative dermatitis, SJS/TEN\nCommon\ndyspepsia, nausea/vomiting, abdominal pain, diarrhea, constipation, flatulence\nheadache, dizziness, drowsiness, tinnitus\ndizziness\nrash, pruritus, urticaria, photosensitivity\nfluid retention, peripheral edema\necchymosis\nelevated creatinine, ALT/AST\nsinusitis",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pharmacology": {
      "text": "Half-life: 1.9 hours\nMetabolism: liver; CYP450 (2C8, 2C9, 3A4 substrate), UGT (2B7 substrate)\nExcretion: urine 65%, bile 35%\nMechanism of Action: exact MOA unknown; inhibits cyclooxyrgenase, reducing prostaglandin and thromboxane synthesis",
      "subsections": {},
      "tables": [],
      "links": []
    }
  }
}